top of page



Morning Sessions

Bridging the Future:

Closing the Equity Gaps in Healthcare Education

Adaptive Leadership:

Paths to Health Security in Multi-Crisis Settings


Burnout in Healthcare Providers:

A Call to Action for Patient and Provider Safety


Leadership in a Post-Roe World:

What Is the Role of Healthcare Organizations?

Afternoon Sessions

The Changemakers’ Playbook:

Perspectives on Disrupting Healthcare Research Funding

Bridging the Gap:

Collaborating for Improved Access to Human Services in
Under-served Communities

Rising Costs of Healthcare:

How Can Hospital Leaders Balance Hospital Financial Solvency with Affordable and Accessible Patient Care?

Managing Technology in Healthcare:

Personalization or Standardization?

Panel Sessions



If the preview below doesn't work, the link to preview and download the full agenda is available below.



Click on the link below to access the full program book!



The faculty, students, and alumnae of the Health Management Program at the Yale School of Public Health are proud to celebrate and honor the memory of Professor John D. Thompson with the John D. Thompson Distinguished Visiting Fellow Award. This award pays tribute to Professor Thompson’s contributions as an educator, researcher, and mentor in health administration, including his pioneering work in healthcare finance and hospital quality of care.

This year, we are proud to present this award to Dr. Mary-Ann Etiebet.

Dr. Mary-Ann Etiebet has over two decades of experience working across public and private sectors to improve healthcare outcomes for underserved populations and transform care delivery at the frontlines. She joined Merck in 2016 where she now serves as the AVP of Health Equity and is responsible for the development and execution of the company’s first enterprise-wide health equity strategy. She also serves as Lead of Merck for Mothers, the company’s $650M global health initiative that has increased access to quality maternal health care and family planning services for over 18M women in 60 countries.

Dr. Etiebet holds an M.D. and M.B.A. from Yale University. She is a member of the World Bank’s Global Financing Facility Investors Group, and also serves on the Board of Directors for Vital Strategies and the Center for Global Development.

Headshot_Mary-Ann Etiebet 12 28 2022.jpg

John D. Thompson (1917-1992) was a Professor at Yale’s Schools of Nursing, Medicine, and Public Health, and is perhaps best known for his role in the development of Diagnosis Related Groups (DRGs) for hospital reimbursement. A true innovator, Professor Thompson was an early advocate for the application of quantitative data in health policy formulation. Today’s healthcare management students and leaders continue to be inspired by his compassion for patients, dedication to research, and belief in the power of data. The John Devereaux Thompson Academic Development Fund was created in his honor.

Keynote Speaker

Alissa Hsu Lynch, MBA
Health Tech Innovator, Board Director, and Henry Crown Fellow 

Recognized by Fierce Healthcare as one of the most influential minority healthcare executives in2022, Alissa has 25 years of global health technology, MedTech, and Consumer Goodsexperience at companies including Google and Johnson & Johnson. As the Global Lead ofMedTech Strategy and Solutions at Google Cloud, she launched market-leading innovation andpartnered with Fortune 500 and startup companies to drive digital transformation in healthcare.Previously, she was Vice President at Johnson & Johnson and led multibillion-dollar internationalbusinesses in operational and strategic roles. Her global experience includes living and workingin the U.S., China, and Europe.Alissa serves on the Board of Directors of Pulmonx (NASDAQ: LUNG), on the Board of Trustees ofAmerican Ballet Theatre, and is a Henry Crown Fellow of the Aspen Institute. She was named tothe Financial Times Agenda Diversity 100 and holds 2 design patents.Before her business career, Alissa lived her childhood dream of becoming a professional dancer.She toured internationally for 6 years with the Limón Dance Company and Ralph Limón  Dance,performing at some of the world’s most prestigious venues including the Kennedy Center for thePerforming Arts, Lincoln Center, and the Cannes Dance Festival. She earned an A.B. in EnglishLiterature at Princeton University and her M.B.A. at Columbia Business School. 

Panel Moderator

 Bridging the future: 
Closing equity gap in healthcare education

Darine Latimore, MD
Deputy Dean and Chief Diversity Officer and
Associate Professor of Internal Medicine (General Medicine); 
Title IX Deputy Coordinator, Office of the Dean, School of Medicine; 
Discrimination and Harassment Coordinator, Office of the President 

Darin Latimore, M.D. is Yale School of Medicine’s (YSM) first deputy dean for diversity and inclusion and its first chief diversity officer. He is devoted to increasing diversity within medical and academic spaces and to improving the climate of YSM’s learning and working environments. He is responsible for and implementing YSM’s comprehensive diversity strategic plan, which includes a focus on recruitment and retention of faculty and students from backgrounds that have been historically underrepresented in science and medicine, while creating an inclusive environment for all YSM’s community.

In his role, he has implemented a comprehensive program to improve faculty diversity and retention that focuses on policies, programs, and building community. He also oversees programs that support the outreach, recruitment, success, and retention of YSM students and postdoctoral fellows. He is co-chair of the YSM Program for Art in Public Spaces, which has commissioned new works of art featuring diverse YSM leaders and has hosted public exhibits that feature artwork by and about members of the YSM community.

Dr. Latimore joined Yale in 2017 from the University of California, Davis School of Medicine, where he was associate dean for student and resident diversity. After obtaining his medical degree at University of California, Davis School of Medicine and completing his residency in internal medicine at University of California, Davis Medical Center.

Amanda Skinner, MSN, MBA
President and CEO of Planned Parenthood Southern New England

Panel Moderator

Leadership in a Post Roe World:
What is the role of healthcare organizations?

Amanda Skinner, MSN, MBA is the President and CEO of Planned Parenthood Southern New England. She holds an MSN from the Yale School of Nursing and an MBA from the Yale School of Management. Prior to Planned Parenthood, she served as Vice President and General Manager, Managed Value and Risk Analytics at Optum, a subsidiary of UnitedHealth Group. Skinner has also worked as a consultant with the Chartis Group, and as Executive Director of Clinical Integration and Population Health for Yale New Haven Health System. Skinner spent ten years in clinical practice as a nurse midwife, serving for four years as the Chair of the Connecticut Chapter of the American College of Nurse Midwives.

Panel Moderator

Burnout in Healthcare Providers:
A Call to Action for Patient and Provider Safety

Kristine Olson, MD, MSc
Chief Wellness Officer, Yale New Haven Hospital  

Kristine Olson is Chief Wellness Officer at Yale New Haven Hospital, a 1541-bed tertiary medical center and primary teaching hospital of Yale School of Medicine. She has demonstrated ability to work collaboratively and creatively to mobilize and orchestrate a system-wide organizational response to assessments resulting in overall lower burnout and higher professional fulfillment for the professional workforce, with improvement in comparison to national benchmarks. These achievements are known to improve individual and organizational performance with retention of talent and return on investment. Dr.Olson is nationally and internationally recognized for modeling, measuring, and managing professional wellbeing. She is a mentor and transformational coach. Dr. Olson is trained in Internal Medicine and Pediatrics at Yale New Haven Hospital, followed by an NIH/AHRQ fellowship in Health Services Research and Epidemiology at Weill Cornell Medical College, with an additional two years of executive education at Yale School of Management. In addition to extensive experience in clinical patient care and clinical operations, Dr. Olson has a decade experience in laboratory bench research as a molecular biologist (neuroscience, infectious diseases). She earned her diploma in Tropical Medicine and Traveler’s Health from Uniformed Services University of the Health Services (including disaster preparedness). Dr. Olson is a Returned Peace Corps Volunteer (Africa). She is experienced in global health in post conflict zones, teaching, and community development. 

Vanessa Kerry, MD, MSc
Associate Professor of Medicine, Harvard Medical School ;
CEO, Seed Global Health;

Instructor in Medicine, Massachusetts General Hospital;
Associate Director of Partnerships and Glob
al Initiatives, Massachusetts General Hospital Center for Global Health;
Director, Program in Global Public Policy and Social Change,
nt of Global Health and Social Medicine, Harvard Medical Schoo


Panel Moderator

Adaptive Leadership:
Paths to Health Security in Multi-Crisis Settings

Dr. Kerry is the co-founder and CEO of Seed Global Health (Seed), a non-profit that focuses on the power of investing in health and the health workforce for social well-being, economic growth, equity which transforms countries. Through partnership with governments and in-country academic institutions, under Vanessa’s tenure Seed has helped train close to 40,000 doctors, nurses and midwives and has impacted hundreds of thousands of lives. Seed's impact is rooted in its unique leveraging model that not only provides better care to patients, but also trains future generations, supports the health sector and catalyzes change in the health system. 
Dr. Kerry’s work has been featured at conferences, in print, online and media including the Aspen Ideas Festival, the United Nations, the World Health Assembly, NPR, PBS, MSNBC and Marie Claire, the New England Journal of Medicine, the New York Times and The Lancet.
She graduated from Yale University (1999) summa cum laude and Harvard Medical School cum laude, completing her clinical training at Massachusetts General Hospital. She earned her Master’s in Health Policy, Planning, and Financing from the London Schools of Economics and of Hygiene and Tropical Medicine. She is currently a critical care physician at Massachusetts General Hospital (MGH) and serves as the Associate Director of Partnerships and Global Initiatives at MGH Global Health. She directs the Global Public Policy and Social Change program at Harvard Medical School where she has focused on links between security and health. She is a Draper Richards Kaplan Foundation Social Entrepreneur, a World Economic Forum Young Global Leader and a member of the Council on Foreign Relations. She is on the Editorial Board of New England Journal of Medicine Evidence and Annals of Global Health. She as awarded an Honorary Doctorate in Public Policy from Northeastern University in 2015. She was recently appointed to the prestigious President’s Council for International Activities at Yale University, as a Global Advisor to the Wellbeing Foundation Africa. She is the mother of an eight- and eleven- year old. 

Panel Moderator

Changemaker's playbook:
Perspectives on disrupting healthcare research funding

Stephen Knight, MD, MBA
President & Managing Partner, F'Prime Capital

Stephen Knight joined F-Prime Capital in 2003 where he serves as President and Managing Partner. He has worked in the pharmaceutical and biotechnology industries for over 30 years and invests broadly across healthcare. Steve serves on the Board of Directors of Aerium Therapeutics, Atalanta Therapeutics, Ensoma, Genomics plc, Leyden Labs, Paradigm, Proof Diagnostics, Pulmocide and Skyline Therapeutics. Steve previously served on the boards of several private and public health care companies including Beam Therapeutics (NASDAQ: BEAM), Blueprint Medicines (NASDAQ: BPMC), Denali Therapeutics (NASDAQ: DNLI), FoldRx Pharmaceuticals (acquired by Pfizer), Innovent Biologics (1801.HK), Iora Health (acquired by One Medical), Ironwood Pharmaceuticals (NASDAQ: IRWD), NextWave Pharmaceuticals (acquired by Pfizer), Prime Medicine (NASDAQ: PRME), Proteostasis Therapeutics (NASDAQ: PTI), Respivert, Ltd (acquired by J&J), Sana Biotechnology (NASDAQ: SANA) and Semma Therapeutics (acquired by Vertex).

Prior to joining F-Prime Capital, Steve held various senior management roles in private and public biotechnology and consulting companies. He also was a researcher at AT&T Bell Laboratories, the National Institutes of Health, and Yale University. He holds an M.D. from the Yale University School of Medicine, an M.B.A. from the Yale School of Organization and Management and received a B.S. in biology from Columbia University, graduating summa cum laude and Phi Beta Kappa.

Panel Moderator

Case Study: Access to Human Services in New Haven

Suzane Lagarde, MD, MBA, FACP
CEO, Fair Haven Community Healthcare

Dr. Lagarde currently serves as CEO of Fair Haven Community Health Care (FHCHC), a Federally Qualified Health Center providing comprehensive healthcare to over 32,000, primarily low income, minority patients. In this role, she oversees a staff of nearly 300 who provide care at 18 locations throughout southern CT. In her nearly 10 years at the helm of FHCHC, she has overseen considerable growth, with the addition of several new clinical sites and new clinical services. Trained as a gastroenterologist, Dr. Lagarde was a founding member of CT Gastroenterology Consultants, a large private practice in southern CT where she worked for many years prior to her current position. She is an Assistant Clinical Professor of Medicine at Yale University and attending gastroenterologist at Yale New Haven Hospital. Dr. Lagarde is a founding member and past president of Project Access-New Haven, a non-profit which provides access to specialty care for the uninsured. She has devoted her career to improving health care for the underserved. Dr. Lagarde advocates for the underserved at city, state, and national levels.

She has served on many key committees, including the Steering Committee of CT SIM (State Innovation Model) charged with healthcare reform in the state of CT. She currently serves on the Medical Assistance Program Oversight Council (MAPOC) for the state of CT, the agency with direct oversight of the Medicaid Program in CT. She has served on the Ambulatory Care Accreditation Advisory Council of The Joint Commission, the sole representative of FQHCs nationwide. She is the immediate past chair of the Board of Directors of The Connecticut Hospice in Branford CT and is the incoming Chair of the Board of Directors of Community Health Network (CHN), the Ambulatory Services Organization (ASO) for CT Medicaid medical. She is committed to practice transformation and currently serves on the Alternate Payment Methodology committee of the Community Health Center Association of CT. 

Panel Moderator

Rising Costs of Healthcare: How Can Hospital
Leaders Balance HospitalFinancial Solvency with
Affordable and Accessible Patient Care? 

Zack Cooper, PhD
Associate Professor of Public Health (Health Policy),
Associate Professor of Economics,
Associate Professor in the Institution for Social and Policy Studies
​Yale School of Public Health

Zack Cooper is an Associate Professor of Public Health and Associate Professor of Economics at Yale University. He also serves as Director of Health Policy at Yale's Institution for Social and Policy Studies. In his academic work, he has analyzed the impact of competition in hospital and insurance markets, studied the influence of price transparency on consumer behavior, investigated the causes of surprise out-of-network bills, and examined the influence of electoral politics on health care spending growth. Cooper received his undergraduate degree from the University of Chicago and his PhD from the London School of Economics

Panel Moderator

Managing Technology in Healthcare:
Personalization or Standardization?

David Rosenthal, MD
Assistant Professor of Medicine (General Medicine);
Healthcare Venture Partner, AlleyCorp

Dr. Rosenthal is a Primary Care Physician, faculty at Yale School of Medicine, Healthcare Venture Partner at Alleycorp, EIR at Yale's Center for Biomedical Innovation and Technology, and medical advisor and angel investor to multiple medical device, digital health, and care delivery ventures. For the past decade, he served as Medical Director of the Homeless Patient Aligned Care Team for VA Connecticut, an award-winning medical home model of care with specialized access for Veterans experiencing homelessness helping Connecticut become the first state to end chronic homelessness among Veterans in 2015. Since 2020 he served as a Medical Director for the City of New Haven’s COVID Isolation respite facility and Chief Medical Officer of Tesseract Health, Liminal Sciences, and Chair of the Medical Advisory Board for 4Catalyzer in Guilford, CT. Dr. Rosenthal graduated magna cum laude from Harvard College with a degree in Visual and Environmental Studies, received his M.D. from Feinberg School of Medicine, Northwestern University, and completed his internship and primary care residency at the Brigham and Women's Hospital in the Management and Leadership Track.

Additional panelists to be announced soon!

bottom of page